Yogesh Singh

Bathinda, PB, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Structure-Based De Novo Design of Novel Dual DPP IV and PTP 1B Inhibitors (DDPI's).

Structure-Based De Novo Design of Novel Dual DPP IV and PTP 1B Inhibitors (DDPI's).

Journal: Chemistry & biodiversity

Published: August 08, 2025

Exploring the Potential of Essential Oil from Plectranthus amboinicus Leaves against Breast Cancer: In vitro and In silico Analysis.

Exploring the Potential of Essential Oil from Plectranthus amboinicus Leaves against Breast Cancer: In vitro and In silico Analysis.

Journal: Medical oncology (Northwood, London, England)

Published: January 03, 2024

Pharmacophore derived 3D-QSAR, molecular docking, and simulation studies of quinoxaline derivatives as ALR2 inhibitors.

Pharmacophore derived 3D-QSAR, molecular docking, and simulation studies of quinoxaline derivatives as ALR2 inhibitors.

Journal: Journal of biomolecular structure & dynamics

Published: September 12, 2023

Developing our knowledge of the quinolone scaffold and its value to anticancer drug design.

Developing our knowledge of the quinolone scaffold and its value to anticancer drug design.

Journal: Expert opinion on drug discovery

Published: August 18, 2023

Polycystic ovary syndrome: Current scenario and future insights.

Polycystic ovary syndrome: Current scenario and future insights.

Journal: Drug discovery today

Published: August 08, 2023

Boron in cancer therapeutics: An overview.

Boron in cancer therapeutics: An overview.

Journal: Pharmacology & therapeutics

Published: July 26, 2023

Medicinal Aspects of PTP1B Inhibitors as Anti-Breast Cancer Agents: An Overview.

Medicinal Aspects of PTP1B Inhibitors as Anti-Breast Cancer Agents: An Overview.

Journal: Current medicinal chemistry

Published: May 23, 2023

An amalgamated molecular dynamic and Gaussian based 3D-QSAR study for the design of 2,4-thiazolidinediones as potential PTP1B inhibitors.

An amalgamated molecular dynamic and Gaussian based 3D-QSAR study for the design of 2,4-thiazolidinediones as potential PTP1B inhibitors.

Journal: Journal of molecular graphics & modelling

Published: May 18, 2023

Molecular docking, 3D-QSAR and simulation studies for identifying pharmacophoric features of indole derivatives as 17β-hydroxysteroid dehydrogenase type 5 (17β-HSD5) inhibitors.

Molecular docking, 3D-QSAR and simulation studies for identifying pharmacophoric features of indole derivatives as 17β-hydroxysteroid dehydrogenase type 5 (17β-HSD5) inhibitors.

Journal: Journal of biomolecular structure & dynamics

Published: February 06, 2023

Dual aromatase-steroid sulfatase inhibitors (DASI's) for the treatment of breast cancer: a structure guided ligand based designing approach.

Dual aromatase-steroid sulfatase inhibitors (DASI's) for the treatment of breast cancer: a structure guided ligand based designing approach.

Journal: Journal of biomolecular structure & dynamics

Published: December 13, 2022

Flavonoids as promising anticancer agents: an in silico investigation of ADMET, binding affinity by molecular docking and molecular dynamics simulations.

Flavonoids as promising anticancer agents: an in silico investigation of ADMET, binding affinity by molecular docking and molecular dynamics simulations.

Journal: Journal of biomolecular structure & dynamics

Published: September 27, 2022

Phosphate Prodrugs: An Approach to Improve the Bioavailability of Clinically Approved Drugs.

Phosphate Prodrugs: An Approach to Improve the Bioavailability of Clinically Approved Drugs.

Journal: Current medicinal chemistry

Published: September 19, 2022

Showing 1-12 of 17

Last Updated: 09/26/2026